Jiang Tao Yu
Directeur/Membre du Conseil chez MingMed Biotechnology Co., Ltd.
Postes actifs de Jiang Tao Yu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
MingMed Biotechnology Co., Ltd.
 MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Directeur/Membre du Conseil | 10/02/2021 | - |
Historique de carrière de Jiang Tao Yu
Formation de Jiang Tao Yu
| Tsinghua University | Graduate Degree |
| Cornell University | Doctorate Degree |
Statistiques
Internationale
| Chine | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
- Bourse
- Insiders
- Jiang Tao Yu
- Expérience
